Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001408294 | SCV001610291 | likely benign | not provided | 2024-12-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001408294 | SCV001801237 | uncertain significance | not provided | 2020-12-21 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Ambry Genetics | RCV002553436 | SCV003543292 | uncertain significance | Inborn genetic diseases | 2021-10-29 | criteria provided, single submitter | clinical testing | The c.4193A>C (p.Q1398P) alteration is located in exon 56 (coding exon 56) of the COL11A1 gene. This alteration results from a A to C substitution at nucleotide position 4193, causing the glutamine (Q) at amino acid position 1398 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV004531243 | SCV004710435 | uncertain significance | COL11A1-related disorder | 2024-02-26 | no assertion criteria provided | clinical testing | The COL11A1 c.4193A>C variant is predicted to result in the amino acid substitution p.Gln1398Pro. This variant was reported in an individual with cleft lip and cleft palate (Dąbrowska et al 2022. PubMed ID: 35778651). This variant is reported in 0.011% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |